Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors.

Abstract:

:Vascular endothelial growth factor receptor 2 (VEGFR2) has been proven to play a major role in the regulation of tumor angiogenesis. A series of novel glycyrrhetic acid derivatives were synthesized and evaluated for their VEGFR2 inhibitory activity as well as their antiproliferative properties against four cancer cell lines (MCF-7, HeLa, HepG2, and A549). In vitro biological evaluations against these human tumor cell lines indicate that most of the prepared compounds have antiproliferative activities; compound 3 a (3β-hydroxy-30-(4-phenyl-1-piperazinyl)olean-12-ene-11,30-dione) exhibited the best inhibitory activity against MCF-7 cells, with an IC50 value of 1.08 μm. Compound 3 a also showed the most potent inhibitory activity against VEGFR2 tyrosine kinase, with an IC50 value of 0.35 μm. Docking simulations were performed with the aim of discovering the binding mode of compound 3 a, and the results indicate that 3 a could bind at the VEGFR2 active site.

journal_name

ChemMedChem

journal_title

ChemMedChem

authors

Yan TL,Bai LF,Zhu HL,Zhang WM,Lv PC

doi

10.1002/cmdc.201700271

subject

Has Abstract

pub_date

2017-07-06 00:00:00

pages

1087-1096

issue

13

eissn

1860-7179

issn

1860-7187

journal_volume

12

pub_type

杂志文章
  • Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth.

    abstract::We synthesized potential inhibitors of farnesyl diphosphate synthase (FPPS), undecaprenyl diphosphate synthase (UPPS), or undecaprenyl diphosphate phosphatase (UPPP), and tested them in bacterial cell growth and enzyme inhibition assays. The most active compounds were found to be bisphosphonates with electron-withdraw...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600343

    authors: Desai J,Wang Y Dr,Wang K Dr,Malwal SR Dr,Oldfield E

    更新日期:2016-10-06 00:00:00

  • CHIPMUNK: A Virtual Synthesizable Small-Molecule Library for Medicinal Chemistry, Exploitable for Protein-Protein Interaction Modulators.

    abstract::A common issue during drug design and development is the discovery of novel scaffolds for protein targets. On the one hand the chemical space of purchasable compounds is rather limited; on the other hand artificially generated molecules suffer from a grave lack of accessibility in practice. Therefore, we generated a n...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700689

    authors: Humbeck L,Weigang S,Schäfer T,Mutzel P,Koch O

    更新日期:2018-03-20 00:00:00

  • A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.

    abstract::Protein tyrosine phosphatase 1B (PTP1B) is an important target for the treatment of diabetes. A series of thiazolidin-4-one derivatives 8-22 was designed, synthesized and investigated as PTP1B inhibitors. The new molecules inhibited PTP1B with IC50 values in the micromolar range. 5-(Furan-2-ylmethylene)-2-(4-nitrophen...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000055

    authors: Patel AD,Pasha TY,Lunagariya P,Shah U,Bhambharoliya T,Tripathi RKP

    更新日期:2020-07-03 00:00:00

  • Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants.

    abstract::Herein we report the design, synthesis, X-ray structural, and biological studies of an exceptionally potent HIV-1 protease inhibitor, compound 5 ((3S,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl ((2S,3R)-4-((2-(cyclopropylamino)-N-isobutylbenzo[d]thiazole)-6-sulfonamido)-1-(3,5-difluorophenyl)-3-hydroxybutan-...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700824

    authors: Ghosh AK,Rao KV,Nyalapatla PR,Kovela S,Brindisi M,Osswald HL,Sekhara Reddy B,Agniswamy J,Wang YF,Aoki M,Hattori SI,Weber IT,Mitsuya H

    更新日期:2018-04-23 00:00:00

  • A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.

    abstract::Into the fold: Prion diseases are neurodegenerative disorders characterized by the accumulation in the brain of a self-replicating, misfolded isoform (PrPSc ) of the cellular prion protein (PrPC ). No therapies are available for these pathologies. We capitalized on previously described cell-based assays to screen a li...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700302

    authors: Massignan T,Sangiovanni V,Biggi S,Stincardini C,Elezgarai SR,Maietta G,Andreev IA,Ratmanova NK,Belov DS,Lukyanenko ER,Belov GM,Barreca ML,Altieri A,Kurkin AV,Biasini E

    更新日期:2017-08-22 00:00:00

  • Design, synthesis, biological evaluation, and molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse transcriptase inhibitors.

    abstract::TIBO- and TBO-like sulfone derivatives 1 and 2 were designed, synthesized, and tested for their ability to block the replication cycle of HIV-1 in infected cells. The anti-HIV-1 activities of sulfones 3, which were intermediates in the syntheses of 1 and 2, were also evaluated. Surprisingly, the sulfone analogues of T...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200500020

    authors: Di Santo R,Costi R,Artico M,Ragno R,Lavecchia A,Novellino E,Gavuzzo E,La Torre F,Cirilli R,Cancio R,Maga G

    更新日期:2006-01-01 00:00:00

  • Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia.

    abstract::Small-molecule inhibitors of hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) are currently under clinical development as novel treatment options for chronic kidney disease (CKD) associated anemia. Inhibition of HIF-PH mimics hypoxia and leads to increased erythropoietin (EPO) expression and subsequently increas...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700783

    authors: Beck H,Jeske M,Thede K,Stoll F,Flamme I,Akbaba M,Ergüden JK,Karig G,Keldenich J,Oehme F,Militzer HC,Hartung IV,Thuss U

    更新日期:2018-05-23 00:00:00

  • Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugs.

    abstract::The glucocorticoid receptor (GR) is a member of the nuclear receptor superfamily that affects immune response, development, and metabolism in target tissues. Glucocorticoids are widely used to treat diverse pathophysiological conditions, but their clinical applicability is limited by side effects. A prediction of the ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800274

    authors: Spreafico M,Ernst B,Lill MA,Smiesko M,Vedani A

    更新日期:2009-01-01 00:00:00

  • Naphthyridines as novel BET family bromodomain inhibitors.

    abstract::Bromodomains (BRDs) are small protein domains found in a variety of proteins that recognize and bind to acetylated histone tails. This binding affects chromatin structure and facilitates the localisation of transcriptional complexes to specific genes, thereby regulating epigenetically controlled processes including ge...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300259

    authors: Mirguet O,Lamotte Y,Chung CW,Bamborough P,Delannée D,Bouillot A,Gellibert F,Krysa G,Lewis A,Witherington J,Huet P,Dudit Y,Trottet L,Nicodeme E

    更新日期:2014-03-01 00:00:00

  • Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.

    abstract::Iridium(III) complexes of the type [Ir(η(5) -C5 Me5 )Cl2 {Ph2 PCH2 CH2 CH2 S(O)x Ph-κP}] (x=0-2; 1-3) and [Ir(η(5) -C5 Me5 )Cl{Ph2 PCH2 CH2 CH2 S(O)x Ph-κP,κS}][PF6 ] (x=0-1; 4 and 5) with 3-(diphenylphosphino)propyl phenyl sulfide, sulfoxide, and sulfone ligands Ph2 PCH2 CH2 CH2 S(O)x Ph were designed, synthesized, a...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300479

    authors: Ludwig G,Ranđelović I,Maksimović-Ivanić D,Mijatović S,Bulatović MZ,Miljković D,Korb M,Lang H,Steinborn D,Kaluđerović GN

    更新日期:2014-07-01 00:00:00

  • Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome.

    abstract::The NLRP3 inflammasome is an important regulator of the sterile inflammatory response, and its activation by host-derived sterile molecules leads to the intracellular activation of caspase-1, processing of the pro-inflammatory cytokines interleukin-1β (IL-1β)/IL-18, and pyroptotic cell death. Inappropriate activation ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201700731

    authors: Baldwin AG,Tapia VS,Swanton T,White CS,Beswick JA,Brough D,Freeman S

    更新日期:2018-02-20 00:00:00

  • 4-Alkylated Silver-N-Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells.

    abstract::Computational chemistry has shown that backbone-alkylated imidazoles ought to be efficient ligands for transition metal catalysts with improved carbene-to-metal donation. In this work, such alkylated imidazoles were synthesized and complexed with silver(I) by means of an eight/nine-step synthetic pathway we devised to...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500234

    authors: Sandtorv AH,Leitch C,Bedringaas SL,Gjertsen BT,Bjørsvik HR

    更新日期:2015-09-01 00:00:00

  • Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.

    abstract::Src homology 2 (SH2)-domain-mediated interactions with phosphotyrosine (pY)-containing ligands are critical for the regulation of SHP-1 phosphatase activity. Peptides based on a binding site from receptor tyrosine kinase Ros (EGLN-pY2267-MVL, 1) have recently been shown to bind to the SHP-1 N-terminal SH2 domain (N-SH...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600037

    authors: Hampel K,Kaufhold I,Zacharias M,Böhmer FD,Imhof D

    更新日期:2006-08-01 00:00:00

  • Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.

    abstract::A severe limitation in cancer therapy is the often insufficient differentiation between malign and benign tissue using known chemotherapeutics. One approach to decrease side effects is antibody-directed enzyme prodrug therapy (ADEPT). We have developed new glycosidic prodrugs such as (-)-(1S)-26 b based on the antibio...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200800250

    authors: Tietze LF,von Hof JM,Krewer B,Müller M,Major F,Schuster HJ,Schuberth I,Alves F

    更新日期:2008-12-01 00:00:00

  • Organoruthenium Prodrugs as a New Class of Cholinesterase and Glutathione-S-Transferase Inhibitors.

    abstract::A small library of 17 organoruthenium compounds with the general formula [RuII (fcl)(chel)(L)]n+ (in which fcl=face capping ligand, chel=chelating bidentate ligand, and L=monodentate ligand) were screened for inhibitory activity against cholinesterases and glutathione-S-transferases of human and animal origins. Compou...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800432

    authors: Ristovski S,Uzelac M,Kljun J,Lipec T,Uršič M,Zemljič Jokhadar Š,Žužek MC,Trobec T,Frangež R,Sepčić K,Turel I

    更新日期:2018-10-22 00:00:00

  • Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.

    abstract::We previously found that p97 ATPase inhibitors 2-(2-amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine (ML240) and 2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine (ML241) specifically target the D2 domain of wild-type p97. In addition, one of the major p97 cofactors,...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402420

    authors: Fang CJ,Gui L,Zhang X,Moen DR,Li K,Frankowski KJ,Lin HJ,Schoenen FJ,Chou TF

    更新日期:2015-01-01 00:00:00

  • Understanding of molecular substructures that contribute to hERG K+ channel blockade: synthesis and biological evaluation of E-4031 analogues.

    abstract::Cardiotoxicity is a common side effect of a large variety of drugs that is often caused by off-target human ether-à-go-go-related gene (hERG) potassium channel blockade. In this study, we designed and synthesized a series of derivatives of the class III antiarrhythmic agent E-4031. These compounds where evaluated in a...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201100366

    authors: Vilums M,Overman J,Klaasse E,Scheel O,Brussee J,IJzerman AP

    更新日期:2012-01-02 00:00:00

  • A Novel Hybrid of Chloroquine and Primaquine Linked by Gold(I): Multitarget and Multiphase Antiplasmodial Agent.

    abstract::Plasmodium parasites kill 435 000 people around the world every year due to unavailable vaccines, a limited arsenal of antimalarial drugs, delayed treatment, and the reduced clinical effectiveness of current practices caused by drug resistance. Therefore, there is an urgent need to discover and develop new antiplasmod...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.202000653

    authors: de Souza Pereira C,Costa Quadros H,Magalhaes Moreira DR,Castro W,Santos De Deus Da Silva RI,Botelho Pereira Soares M,Fontinha D,Prudêncio M,Schmitz V,Dos Santos HF,Gendrot M,Fonta I,Mosnier J,Pradines B,Navarro M

    更新日期:2020-11-24 00:00:00

  • A Flexible Strategy for Modular Synthesis of Curcuminoid-BF2 /Curcuminoid Pairs and Their Comparative Antiproliferative Activity in Human Cancer Cell Lines.

    abstract::A facile protocol that enables synthetic interconversion of CUR-BF2 and CUR compounds is described that significantly widens the preparative scope of curcuminoids, providing access to larger libraries of compounds, thus enabling comparative antiproliferative and apoptotic study of a larger library of synthetic analogs...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201900640

    authors: Abonia R,Laali KK,Raja Somu D,Bunge SD,Wang EC

    更新日期:2020-02-17 00:00:00

  • Photodelivery of CO by designed PhotoCORMs: correlation between absorption in the visible region and metal-CO bond labilization in carbonyl complexes.

    abstract::The therapeutic potential of photoactive CO-releasing molecules (photoCORMs) have called for close examination of the roles of the ligand(s) and the central metal atoms on the overall photochemical labilization of the metal-CO bonds. Along this line, we have synthesized four metal complexes, namely, [MnBr(azpy)(CO)3 ]...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402007

    authors: Chakraborty I,Carrington SJ,Mascharak PK

    更新日期:2014-06-01 00:00:00

  • Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor.

    abstract::The Eph-ephrin system, including the EphA2 receptor and the ephrinA1 ligand, plays a critical role in tumor and vascular functions during carcinogenesis. We previously identified (3α,5β)-3-hydroxycholan-24-oic acid (lithocholic acid) as an Eph-ephrin antagonist that is able to inhibit EphA2 receptor activation; it is ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200102

    authors: Tognolini M,Incerti M,Hassan-Mohamed I,Giorgio C,Russo S,Bruni R,Lelli B,Bracci L,Noberini R,Pasquale EB,Barocelli E,Vicini P,Mor M,Lodola A

    更新日期:2012-06-01 00:00:00

  • Light-Switchable Antagonists for the Histamine H1 Receptor at the Isolated Guinea Pig Ileum.

    abstract::The histamine H1 G protein-coupled receptor (GPCR) plays an important role in allergy and inflammation. Existing drugs that address the H1 receptor differ in their chemical structure, pharmacology, and side effects. Light-controllable spatial and temporal activity regulation of photochromic H1 ligands may contribute t...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800815

    authors: Rustler K,Pockes S,König B

    更新日期:2019-03-22 00:00:00

  • Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.

    abstract::(±)-6-Alkyl-2,4-diaminopyrimidine-based inhibitors of bacterial dihydrofolate reductase (DHFR) have been prepared and evaluated for biological potency against Bacillus anthracis and Staphylococcus aureus. Biological studies revealed attenuated activity relative to earlier structures lacking substitution at C6 of the d...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201200291

    authors: Nammalwar B,Bourne CR,Bunce RA,Wakeham N,Bourne PC,Ramnarayan K,Mylvaganam S,Berlin KD,Barrow EW,Barrow WW

    更新日期:2012-11-01 00:00:00

  • Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR.

    abstract::Following the discovery of a type III allosteric modulator of cyclin-dependent kinase 2 (CDK2) characterized by a hexahydrocyclopenta[c]quinolone scaffold, three different series of its derivatives were synthesized and biologically evaluated. Docking of the synthesized compounds into the allosteric pocket of CDK2 allo...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800687

    authors: Carlino L,Christodoulou MS,Restelli V,Caporuscio F,Foschi F,Semrau MS,Costanzi E,Tinivella A,Pinzi L,Lo Presti L,Battistutta R,Storici P,Broggini M,Passarella D,Rastelli G

    更新日期:2018-12-20 00:00:00

  • Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives.

    abstract::Numerous studies have shown that chalcones are promising scaffolds for the development of new monoamine oxidase-B (MAO-B) inhibitors. As a continuation of our ongoing research into the development of reversible human MAO-B (hMAO-B) inhibitors, two series of twenty chalcones containing electron-donating and electron-wi...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201600497

    authors: Mathew B,Uçar G,Mathew GE,Mathew S,Kalatharakkal Purapurath P,Moolayil F,Mohan S,Varghese Gupta S

    更新日期:2016-12-16 00:00:00

  • Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.

    abstract::Polo-like kinase 1 (PLK1) plays crucial functions in multiple stages of mitosis and is considered to be a potential drug target for cancer therapy. The functions of PLK1 are mediated by its N-terminal kinase domain and C-terminal polo-box domain (PBD). Most inhibitors targeting the kinase domain of PLK1 have a selecti...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201402284

    authors: Shan HM,Shi Y,Quan J

    更新日期:2015-01-01 00:00:00

  • Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives.

    abstract::Cellular chaperones that belong to the heat-shock protein 90 (Hsp90) family are a prerequisite for successful viral propagation for most viruses. The hepatitis C virus (HCV) uses Hsp90 for maturation, folding, and modification of viral proteins. Based on our previous discovery that marine alkaloid analogues with a 4,5...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201800724

    authors: Lillsunde KE,Tomašič T,Schult P,Lohmann V,Kikelj D,Tammela P

    更新日期:2019-02-05 00:00:00

  • Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).

    abstract::Protein-protein interactions (PPIs) control many cellular processes in cancer and tumour growth. Of significant interest is the role PPIs play in regulating apoptosis. The overexpression of the antiapoptosis regulating Bcl-2 family of proteins is commonly observed in several cancers, leading to resistance towards both...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201500488

    authors: Beekman AM,O'Connell MA,Howell LA

    更新日期:2016-04-19 00:00:00

  • X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors.

    abstract::Tau-tubulin kinase 1 (TTBK1) is a serine/threonine/tyrosine kinase that putatively phosphorylates residues including S422 in tau protein. Hyperphosphorylation of tau protein is the primary cause of tau pathology and neuronal death associated with Alzheimer's disease. A library of 12 truncation variants comprising the ...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.201300274

    authors: Xue Y,Wan PT,Hillertz P,Schweikart F,Zhao Y,Wissler L,Dekker N

    更新日期:2013-11-01 00:00:00

  • A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

    abstract::Having oxaliplatin as archetype, several platinum complexes with a carbohydrate moiety resembling the cyclohexane-1,2-diamine ligand of oxaliplatin have been prepared. As leaving groups, the anionic ligands iodide, oxalate, and malonate were utilized, and for comparison purposes the chloro complex was employed. All co...

    journal_title:ChemMedChem

    pub_type: 杂志文章

    doi:10.1002/cmdc.200600279

    authors: Berger I,Nazarov AA,Hartinger CG,Groessl M,Valiahdi SM,Jakupec MA,Keppler BK

    更新日期:2007-04-01 00:00:00